Is there another benefit besides weight loss of GLP-1s in people with severe obesity? Elizabeth Tracey reports
About this episode
The episode discusses the potential additional benefits of GLP-1 receptor agonists for individuals with severe obesity and heart failure.
GLP-1 receptor agonists are effective in helping most people lose weight, and now a new study suggests that in those with severe obesity, a BMI of 42 or greater and who have a type of heart failure, this condition may … Is there another benefit besides weight loss of GLP-1s in people with severe obesity? Elizabeth Tracey reports Read More »
People in this episode
Host: Elizabeth Tracey
Topics covered
- GLP-1 receptor agonists
- severe obesity
- weight loss
- heart failure
- BMI
- health benefits
Keywords
- GLP-1
- weight loss
- severe obesity
- heart failure
- BMI
- health benefits
- Johns Hopkins
Mentioned in this episode
Organizations: Johns Hopkins Medicine
Products: GLP-1 receptor agonists
More episodes of Health Newsfeed – Johns Hopkins Medicine Podcasts
- Increasing rates of obesity and severe obesity may presage increased rates of heart failure, Elizabeth Tracey reports
- Can GLP-1 agonists help in heart failure and severe obesity? Elizabeth Tracey reports
- What is severe obesity doing to the heart muscle’s ability to contract? Elizabeth Tracey reports
- How is obesity related to a common form of heart failure? Elizabeth Tracey reports
- A model of your brain may one day be grown in a lab, Elizabeth Tracey reports
- What can be learned from what cells dispose of? Elizabeth Tracey reports
Explore listener stats, chart rankings, contacts and more on the Health Newsfeed – Johns Hopkins Medicine Podcasts podcast page.